Paion AG

PA8

Company Profile

  • Business description

    Paion AG is a holding company engaged in providing various services to the subsidiaries. The group is focused on developing and commercializing medical innovations for procedural sedation, anesthesia, and critical care services. The key product of the company is remimazolam, which is an ultra-short-acting intravenous benzodiazepine sedative. In the human body, remimazolam is rapidly metabolized to an inactive metabolite by tissue esterases and not metabolized by cytochrome-dependent hepatic pathways. The organization is based in Germany.

  • Contact

    Heussstrasse 25
    Aachen52078
    DEU

    T: +49 24144530

    E: [email protected]

    https://www.paion.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2025

    Employees

    64

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,360.0019.000.23%
CAC 407,593.8738.000.50%
DAX 4022,496.9871.150.32%
Dow JONES (US)40,669.36141.740.35%
FTSE 1008,494.8531.390.37%
HKSE22,119.41111.300.51%
NASDAQ17,446.3414.98-0.09%
Nikkei 22536,241.70196.320.54%
NZX 50 Index12,021.14117.830.99%
S&P 5005,569.068.230.15%
S&P/ASX 2008,143.2017.000.21%
SSE Composite Index3,279.037.62-0.23%

Market Movers